Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report) and CytomX Therapeutics (CTMX – Research Report). Irhythm Technologies (IRTC) BTIG analyst Marie Thibault reiterated a Buy rating on Irhythm Technologies yesterday and set a price target of $178.00. The company's shares closed last Thursday at $153.42, close to its 52-week high of $169.54. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-irhythm-technologies-irtc-and-cytomx-therapeutics-ctmx?utm_source=advfn.com&utm_medium=referral
iRhythm Technologies (NASDAQ:IRTC)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more iRhythm Technologies Charts.
iRhythm Technologies (NASDAQ:IRTC)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more iRhythm Technologies Charts.